From: Tryptophan metabolism in digestive system tumors: unraveling the pathways and implications
Tumor type | Tryptophan metabolism | Sample | Clinical characteristics | Functions | Mechanisms | Â |
---|---|---|---|---|---|---|
Esophageal cancer | Trp, 5-HT | Serum | Metastasis | Â | Â | [35] |
Esophageal cancer | 5-HT, 5-HIAA | Serum | Susceptibility, lymph node metastasis, prognosis | Â | [36] | |
Esophageal cancer | TDO2 | Tissue | Lymph node metastasis, clinical stage, prognosis | Cell proliferation, migration, colony formation, tumor growth | AKT, GSK3Î’, IL-8 | [37] |
Esophageal cancer | TDO2 | Tissue | Tumor stage, recurrence status, prognosis | Cell proliferation, spheroid colonies, invasion | PI3K, AKT, ERK | [38] |
Esophageal cancer | IDO1 | Tissue | Prognosis | Â | Â | [39] |
Gastric cancer | Trp, Melatonin, Indole-3-propionic acid | Serum | Â | Â | Â | [41] |
Gastric cancer | Trp | Serum | Sensitivity of predicting gastric cancer | Â | Â | [42] |
Gastric cancer | TDO2 | Tissue | TNM stage, lymphatic invasion status, prognosis | Â | [43] | |
Gastric cancer | Kyn | Serum | Drug resistance | Chemoresistance | IL-10, STAT3, BCL2 | [44] |
Gastric cancer | Trp | Gastric juice | Detection of early gastric cancer | Â | Â | [45] |
Gastric cancer | IDO1 | Tissue | Â | Parietal cell loss, gastric metaplasia | B cell | [46] |
Gastric cancer | IDO1 | Cell | Â | Cell migration | MAPK pathway | [47] |
Gastric cancer | KYNU, Kyn, AhR | Tissue | Â | Metastasis | GPX2 | [48] |
Gastric cancer | KAT2 | Â | Gastric intestinal metaplasia | Â | CGAS, IRF3 | [49] |
Liver cancer | 3-HAA | Tissue | Â | Cell apoptosis, tumor growth | YY1, PKC, DUSP6, ERK1/2 | [50] |
Liver cancer | 5-HT1D | Tissue | Recurrence rate, prognosis | Cell proliferation, epithelial-mesenchymal transition, metastasis | PI3K, AKT, FOXO6 | [51] |
Liver cancer | KMO | Tissue | Tumor differentiation, disease recurrence, prognosis | Cell proliferation, migration, invasion | Â | [52] |
Liver cancer | TDO2 | Tissue | Tumor size, tumor differentiation, m stage, prognosis | Cell migration, invasion, proliferation | CircZNF566, mir-4738-3p | [53] |
Liver cancer | Kyn, Trp | Serum | Increased risk of HCC | Â | Â | [54] |
Liver cancer | IDO1 | Tissue | Prognosis | Â | Â | [55] |
Liver cancer | IDO1 | Tissue | Prognosis | Â | Â | [56] |
Liver cancer | TDO2 | Tissue | Advanced stage, vascular invasion, prognosis | Cell migration, invasion | Â | [57] |
Liver cancer | Trp, Kyn, AhR | Tissue | Â | Cell proliferation, migration | CYP1A1 | [58] |
Liver cancer | TDO2 | Tissue | Tumor size, clinical stage, TNM stage, tumor differentiation, prognosis | Cell proliferation, cell-cycle arrest, tumor growth | P21, P27 | [59] |
Colorectal cancer | Trp | Serum | Â | Â | Â | [60] |
Colorectal cancer | 5-HT | Tissue | Â | Tumor growth | NLRP3, Immortalized bone marrow-derived macrophages | [61] |
Colorectal cancer | IL4I1, AhR, Trp | Tissue | Â | Cell proliferation, migration, invasion | Â | [62] |
Colorectal cancer | KMO | Tissue | Metastasis, prognosis | Sphere-forming, migration, invasion | Â | [63] |
Colorectal cancer | IDO1, TDO2 | Tissue | Lymph node metastasis, tumor stage | Â | Â | [64] |
Colorectal cancer | TDO2, KYNU, AhR | Tissue | Clinical stage, prognosis | Cell proliferation, colony formation, invasion, tumor growth | Â | [65] |
Colorectal cancer | Tryptophanyl-trna synthetase | Tissue | Lymph node metastasis, tumor stage, risk for recurrence, prognosis | Â | [66] | |
Colorectal cancer | IDO1 | Tissue | Â | Cell proliferation, tumor growth | Î’-catenin | [67] |
Colorectal cancer | 5-HT | Tissue | Â | Angiogenesis, tumor growth | Macrophages | [68] |
Colorectal cancer | Kyn, AhR | Cell | Â | Goblet cell differentiation | WNT, NOTCH, HES1, HATH1 | [69] |
Colorectal cancer | IDO1 | Tissue | Â | Cell proliferation, apoptosis, tumor growth | PI3K, AKT | [70] |
Colorectal cancer | TDO2, AhR, Kyn | Tissue | Liver metastasis | Stemness, immune evasion | PD-L1 | [71] |
Colorectal cancer | 8-hydroxyquinaldic acid | Tissue | Â | Cell proliferation, cell cycle, cell migration | Î’-catenin, E-cadherin | [72] |
Colorectal cancer | IAA | Cell | Â | Cell proliferation, cell cycle | TLR4, ERK, JNK | [73] |
Colorectal cancer | KYNA | Cell | Â | Cell proliferation | PI3K, AKT, MAPK, Î’-catenin | [74] |
Colorectal cancer | QA | Cell | Â | Cell proliferation | ERK, P38, CREB, AKT | [75] |
Colorectal cancer | Melatonin | Cell |  | Cell proliferation, apoptosis, angiogenesis | FOXO-1, NF-ΚΒ, Endothelin-1 | [76] |
Pancreatic cancer | 5-HT, TPH1, MAOA | Tissue | Tumor stage, tumor size, prognosis | Cell proliferation, apoptosis, tumor growth | MYC, HIF1A, PI3K, AKT, MTOR | [77] |
Pancreatic cancer | IDO | Tissue | TNM stage, histological differentiation, lymph nodule metastasis | Â | [78] | |
Pancreatic cancer | KYNU | Tissue | Prognosis | Â | NFR2 | [79] |
Pancreatic cancer | IDO1, Kyn, AhR | Tissue | Prognosis | Spheroid growth, invasion | NO•, RUNX3 | [80] |
Pancreatic cancer | AhR, Indoles | Cell | Prognosis | Tumor growth | TAM | [81] |
Pancreatic cancer | 3-HAA, 3-HK | Serum | Increased risk of pancreatic cancer | Â | Â | [82] |